- Home
- ICU vs AEI Comparison
ICU vs AEI Comparison
Compare ICU & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- AEI
- Stock Information
- Founded
- ICU 2018
- AEI 2014
- Country
- ICU United States
- AEI United States
- Employees
- ICU N/A
- AEI N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- AEI Building operators
- Sector
- ICU Health Care
- AEI Real Estate
- Exchange
- ICU Nasdaq
- AEI Nasdaq
- Market Cap
- ICU 10.4M
- AEI 11.2M
- IPO Year
- ICU N/A
- AEI N/A
- Fundamental
- Price
- ICU $1.90
- AEI $0.81
- Analyst Decision
- ICU
- AEI
- Analyst Count
- ICU 0
- AEI 0
- Target Price
- ICU N/A
- AEI N/A
- AVG Volume (30 Days)
- ICU 148.9K
- AEI 169.6K
- Earning Date
- ICU 04-15-2025
- AEI 03-31-2025
- Dividend Yield
- ICU N/A
- AEI N/A
- EPS Growth
- ICU N/A
- AEI N/A
- EPS
- ICU N/A
- AEI N/A
- Revenue
- ICU $68,000.00
- AEI $13,191,488.00
- Revenue This Year
- ICU N/A
- AEI N/A
- Revenue Next Year
- ICU $358.72
- AEI N/A
- P/E Ratio
- ICU N/A
- AEI N/A
- Revenue Growth
- ICU N/A
- AEI N/A
- 52 Week Low
- ICU $1.50
- AEI $0.46
- 52 Week High
- ICU $27.50
- AEI $2.61
- Technical
- Relative Strength Index (RSI)
- ICU 56.41
- AEI 39.76
- Support Level
- ICU $1.60
- AEI $0.82
- Resistance Level
- ICU $1.83
- AEI $0.93
- Average True Range (ATR)
- ICU 0.15
- AEI 0.08
- MACD
- ICU 0.02
- AEI -0.02
- Stochastic Oscillator
- ICU 80.00
- AEI 0.00
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.